08/16- Allison Miller has been appointed to a joint faculty position between the Danforth Plant Science Center and SLU, expanding the collaboration between the two institutions.
07/29- Enrico Di Cera, Chair of Biochemistry and Molecular Biology at SLU, discusses the value of SLU's "Research 2" designation from Carnegie and continuing to climb the Carnegie rankings.
07/18- Gina Yosten is studying how cells of the body communicate, and, when they don’t, where the breakdown occurs and how to fix it.
06/27- Fred Pestello, president of Saint Louis University, talks about the risks and rewards of investing in more research opportunities.
06/08- Fortune writes that SLU's Center for Vaccine Development’s Vaccine and Treatment Evaluation Unit (funded by the National Institutes of Health) is planning a human approach to studying influenza and vaccine effectiveness.
06/02- Saint Louis University is hosting a competition among faculty and students to find the next big idea. Meet the three finalists and learn more about how they are hoping to change the world.
05/16- Dr. Daniel Hoft and his team at the Center for Vaccine Development Extended Stay Research Unit are preparing for their fight against the deadly virus.
05/14- Saint Louis University is among four federally-funded vaccine research centers studying an investigational universal influenza vaccine intended to protect against multiple strains of the virus.
04/30- SLU’s Office of the Vice President for Research (OVPR) and the Research Growth Committee have announced the winners of the first round of Big Ideas planning grants. The multi-year competition offers increasing levels of investment for projects that demonstrate broad faculty engagement, strong leadership and compelling research plans.
04/11- Saint Louis University researchers are one step closer to understanding how to prevent the chronic pain associated with chemotherapy.
04/02- Vice President for Research Ken Olliff was featured as one of "100 St. Louisans You Should Know to Succeed in Business" in the April issue of St. Louis Small Business Monthly.
04/02- Saint Louis University researcher Daniel F. Hoft, M.D., Ph.D., has been named a fellow of the Academy of Science of St. Louis, an organization that works to promote the advancement and understanding of science and technology in the region.
03/29- Saint Louis University’s Department of Family and Community Medicine ranks in the top 20 in the nation in National Institute for Health (NIH) funding, per data compiled by the Blue Ridge Institute for Medical Research.
03/05- 2/28 Researcher Irma Kuljanishvili, Ph.D. developed a promising technique to produce nanoscale materials using simple processes.
02/27- Research by Jeff Scherrer, professor of family and community medicine, was published in the British Journal of Psychiatry.
10/02- SLU's Ken Olliff and Lauren Landfried discuss the importance of a multidisciplinary approach on Fox 2 Now.
09/27- Paul Bracher, Ph.D., assistant professor in the Department of Chemistry at Saint Louis University, talks with the St. Louis Business Journal.
09/20- For Saint Louis University historian and archaeologist Thomas Finan, Ph.D., digging into the past buried in layers of Irish soil is a means to understand the past and to prepare his students for the future. A new documentary from HEC-TV chronicles that journey.
09/12- In research published in Proceedings of the National Academy of Sciences (PNAS), Mee-Ngan F. Yap, Ph.D., assistant professor of biochemistry and molecular biology at Saint Louis University, has uncovered the way a bacterial ribosome moves from an inactive to an active form, and how that “wake up call” is key to its survival.
08/28- Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications.
08/18- "What I've learned along the way is not to hold on too tight to what you think you're supposed to be doing. Don't be afraid to change track along the way."
06/17- Saint Louis University researcher Daniela Salvemini, Ph.D., reports discovering a key molecular pathway that drives cancer-related bone pain while providing a potential solution with a drug that already is on the market.